Skip to content

Etonogestrel

  • Prescription medicine
  • Prescription only
  • Identity checked
  • Sources last checked 2026-09-04

This page shows what was measured, who it was measured in, and what that does not settle.

What Etonogestrel does in the body

Prevention of pregnancy

From the FDA-approved label: The contraceptive effect of NEXPLANON is achieved by suppression of ovulation, increased viscosity of the cervical mucus, and alterations in the endometrium.

What happened in people

RNAWiki has not yet published a reviewed conclusion for this use.

A fixed RNAWiki sentence

Where this came from

Wording RNAWiki always uses, not a finding about this substance.

No reviewed claim names a result for any goal on this record.

No source is stored against this line.

The limit that matters most

Not recorded.

Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
Professional supervision is normally required. A regulator classifies this substance in a way that restricts how it is supplied.

What the registries record it as

  • The substance registry classes this as chemical.

    FDA substance registry · 304GTH6RNH · read 2026-08-29

Where each sentence above came from

No recorded sentence describes the change this makes in a way that stands on its own. The page opens with what it is taken for instead, and the recorded explanation follows below.

Shown as the opening line on this page.

No statement of the main limit is recorded.

The four opening statements run to 42 words.

Words this page uses

Four words worth knowing first

Chosen from what this page shows, with each one explained before the word it depends on.

Biomarker

A biomarker is a number from a test that stands in for something about health.

A picture of it, and where the picture fails

A biomarker is like a fuel gauge.

Where that stops being true. A gauge is wired to the tank. Many biomarkers are only loosely tied to health.

What people get wrong. A better number is read as a better life. Several medicines improved a number and helped nobody.

A measurable indicator used as a substitute for a clinical outcome of interest.

Stand-in result

A stand-in result is a number measured because the real result takes too long.

A picture of it, and where the picture fails

It is like judging a journey by the speedometer rather than by arriving.

Where that stops being true. Speed does predict arrival. Many stand-in results do not predict the real one.

What people get wrong. A stand-in result is often reported as the result itself.

A surrogate endpoint substituted for a clinical endpoint, valid only where the substitution has been shown to hold.

What happened in peopleRead from sources, not yet reviewed

What was measured, goal by goal

One row for each goal a registered study measured something for. One column for each kind of thing that could be measured.

Registered studies list 21 outcome measures that RNAWiki could read. A registered study says what someone planned to measure. It does not say what they found. 0 of the matched studies tested this substance, and 0 posted a result.

There is no single score. A strong test result and a weak life result are different facts.

Goals down the side, kinds of measurement across the top. Each cell says what kind of thing was registered, not what was found.
GoalLife outcomeWhat a body can doHow a person feelsA test resultA step in the bodyHarmsHow longWho was studied
Fertility and sexual healthNothing in the sources checkedNo registered study lists a life outcome for this goal.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Nothing in the sources checkedNo registered study lists a test result for this goal.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
Which registered measures put each goal on this table
Fertility and sexual health
female sexual function

Sorted by fixed word lists, version v1. A name the rules do not recognise stays unsorted rather than moving to the nearest column.

What each mark on this table means
Nothing in the sources checked
No registered study lists a life outcome for this goal.
Not recorded
Harms were not a registered measure for this goal.
Waiting for a reviewer
Who was studied is listed further down the page.

What happened in peopleRead from sources, not yet reviewed

What happened in people

Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.

Relationship Satisfaction

The study did not show it

Who was studied
NCT04950686
How many people
2184
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Vaginal

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Number of In-Treatment Pregnancies Per 100 Woman-Years of Exposure in Participants 18-35 Years of Age (Pearl Index)

The study did not show it

Who was studied
NCT02616146
How many people
2016
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Vaginal

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Number of In-Treatment Pregnancies Per 100 Woman-Years of Exposure in Participants 18-35 Years of Age (Pearl Index)

The study did not show it

Who was studied
NCT02524288
How many people
1941
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Vaginal

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Delay sexual initiation - Survey question

The study did not show it

Who was studied
NCT02539602
How many people
1616
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Vaginal

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Contraceptive use among secondary participants

The study did not show it

Who was studied
NCT03842540
How many people
1099
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Vaginal

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Effectiveness

The study did not show it

Who was studied
NCT02267616
How many people
1076
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Vaginal

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.

What happened in peopleRead from sources, not yet reviewed

How close this is to real life

The top step is something a person would feel or care about. The bottom is a guess from software. Filled steps are where evidence exists for this substance.

  1. Living longer, or avoiding a major event No evidence recorded. Death, a heart attack, a stroke, a hospital stay.No registered study measures this.
  2. What a body can do day to day No evidence recorded. Walking, dressing, breathing, recovering.No registered study measures this.
  3. Measured performance No evidence recorded. How much was lifted, how far was run, how fast.No registered study measures this.
  4. Symptoms and quality of life No evidence recorded. Pain, tiredness, mood, sleep, as the person rated it.No registered study measures this.
  5. A number that stands in for health Evidence recorded. Cholesterol, blood sugar, bone density. A stand-in, not the thing itself.2 registered measures of this kind.
  6. A step measured inside a person Evidence recorded. Something measured in human tissue or human cells.A human record sits on the stored organism ladder.
  7. Animals No evidence recorded. Mice, rats, dogs. Useful for ideas, not proof about people.No animal record is stored.
  8. Cells in a dish No evidence recorded. Cells or chemistry on a bench, far from a whole body.No cell or bench record is stored.
  9. A guess from software No evidence recorded. Nobody measured it. RNAWiki never publishes one as a finding.RNAWiki stores no prediction for this record. Software can suggest a link. RNAWiki does not publish one as a finding.

Higher on these steps means closer to something a person would feel. It does not mean better done.

What it would be like to takeRead from sources, not yet reviewed

Felt, measured, or meaningful

Three different things that get called the same word. Registered studies measured all three, and mixing them is how a blood test becomes a health claim.

Felt

Things a person could notice without a test.

No registered study measured anything of this kind.

Measured

Things only a test, a scale or a device shows.

  • progesterone concentrations 16 / by cycle
  • maximum observed serum concentration

Meaningful

Things that change how a life goes, not only a number.

No registered study measured anything of this kind.

A registered study says what someone planned to measure. It does not say what they found. A number moving is not the same as a life going better. The two are shown apart here.

Felt, but not shown to help. A person notices a change. No study showed it leads anywhere good.

Measured, but not felt. A number moves. The person notices nothing. Both can be true.

Measured, but not shown to matter. A number moves in the good direction. Nobody showed that lives went better.

Matters, but takes years. The result that counts may take longer than anyone would keep watching.

Names that fit none of the three (19)
  • pregnancy
  • adverse events
  • continuation rate
  • contraceptive method discontinuation
  • satisfaction timing of contraceptive administration
  • continuation rate of contraceptive method
  • ovulation incidence by cycle
  • breakthrough bleeding and/or spotting during cycle 3
  • female sexual function
  • time to lactogenesis stage ii
  • treatment related adverse events
  • removal rate of contraceptive implants users
  • satisfactory of contraceptive implant users
  • ovulation implant alone
  • ovulation implant and same day upa
  • changes to mucosal function
  • changes to mucosal health
  • time to cmax
  • who experienced endometrial changes

These are harms, study-process measures, or names the rules did not recognise. They are shown rather than dropped.

What it would be like to takeRead from sources, not yet reviewed

How long anything takes

Nine different lengths of time that get confused with each other. None of them is worked out from another.

  1. Before anything is noticed. RNAWiki does not store this separately, and never works it out from another figure on this page.

  2. Before a test result moves. RNAWiki does not store this separately, and never works it out from another figure on this page.

  3. Before performance moves. RNAWiki does not store this separately, and never works it out from another figure on this page.

  4. How long the result was watched. No finished study window is recorded for a study that tested this substance.

  5. How long people took it. How long people actually took it is not stored. The study window is not the same thing.

  6. How long people were followed. Follow-up length is not stored separately. It is never read off the study window, which would be a different thing.

  7. How fast the body clears it. 25 hours hours

    Read from the label, which states: “Excretion The elimination half-life of etonogestrel is approximately 25 hours.”

  8. How long effects linger. RNAWiki does not store this separately, and never works it out from another figure on this page.

  9. Beyond the studies. Nothing is recorded about the long term.

    The longest finished study sets the edge of what anyone measured.

A study window is not how long people took it, and neither is how long they were followed. Where RNAWiki holds only one of the three, it shows one.

What is missing or unclearRead from sources, not yet reviewed

Were people like you studied?

RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.

Who was studied

People similar to this profile were included.

  • NEXPLANON ® is indicated for prevention of pregnancy in women of reproductive potential for up to 5 years. NEXPLANON is a progestin indicated for prevention of pregnancy in women of reproductive potential for up to 5 years. ( 1 )

Who is missing from the studies

  • Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What the label states about particular groups

  • On pediatric, the label states: “The safety and effectiveness of NEXPLANON have been established in women of reproductive potential.”

    US prescribing information · 487f8a62-e142-457c-97cc-2e398fde7594 · read 2026-08-30

  • On older people, the label states: “This product has not been studied in women over 65 years of age and is not indicated in this population.”

    US prescribing information · 487f8a62-e142-457c-97cc-2e398fde7594 · read 2026-08-30

  • On people who are pregnant, the label states: “Risk Summary NEXPLANON is contraindicated during pregnancy because there is no need for pregnancy prevention in a woman who is already pregnant [see Contraindications (4) ] .”

    US prescribing information · 487f8a62-e142-457c-97cc-2e398fde7594 · read 2026-08-30

  • On people who are breastfeeding, the label states: “Risk Summary Small amounts of contraceptive steroids and/or metabolites, including etonogestrel are present in human milk.”

    US prescribing information · 487f8a62-e142-457c-97cc-2e398fde7594 · read 2026-08-30

  • On people with reduced liver function, the label states: “No studies were conducted to evaluate the effect of hepatic disease on the disposition of NEXPLANON.”

    US prescribing information · 487f8a62-e142-457c-97cc-2e398fde7594 · read 2026-08-30

Where the result stopped carrying

  • This is a scope explorer, not a diagnosis engine.
  • It shows who was studied so you can see whether people similar to you were included.

RNAWiki cannot tell whether a study fits you. It can show who was in it.

What it would be like to takeRead from sources, not yet reviewed

Why it might seem to do nothing

A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.

It was studied for a different goal

The studies measured something else entirely.

On this record: Some registered studies measured things that match no goal on this page.

It was studied in different people

The people in the studies were not much like the reader.

On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

The evidence may simply be wrong

Small early studies often do not hold up.

On this record: RNAWiki has not yet published a reviewed conclusion for this use.

Other reasons RNAWiki checked and found nothing for (10)
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.

None of these is a reason to take more. Taking more is not a step this page ever suggests.

What it would be like to takeRead from sources, not yet reviewed

What taking it involves

The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.

How it is supplied

Prescription only

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Read from the recorded approval status.

No source is stored against this line.

Form and route

Vaginal

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form and route recorded on this substance.

No source is stored against this line.

Who oversees it

Professional supervision is normally required. A regulator classifies this substance in a way that restricts how it is supplied.

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Suppression classes recorded: S5.

No source is stored against this line.

What is in the pack

Sold as ring, implant, insert, extended release, given by the vaginal, implantation, subcutaneous route.

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

Recorded notes on how this is sold and what that means for what is in the pack.

No source is stored against this line.

Where it is registered

Regulatory records are listed in the technical disclosure at the foot of this page.

Counted from records

Where this came from

A count of rows RNAWiki holds. It describes our records, not your body.

Register entries are stored per jurisdiction and shown with their dates.

No source is stored against this line.

Why people stop

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No record of why people stopped taking it is stored for this substance.

No source is stored against this line.

What it would be like to takeNothing found in the sources checked

What can go wrong

Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.

Nothing found in the sources checked

No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Reports sent to a regulator

  • These are reports people sent to a regulator. They do not show the medicine caused the reaction.
  • Nobody counted how many people took the medicine and reported nothing.
  • The same event can be reported more than once, and many reports are incomplete.
  • News coverage, lawsuits and new warnings change how often people report.
  • A count is not a rate and not a risk.

Etonogestrel appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 12865 reaction mentions were counted. One report can name several reactions.

The recorded terms (10)
  • menorrhagia — 1633 reaction mentions
  • unintended pregnancy — 1559 reaction mentions
  • implant site pain — 1353 reaction mentions
  • menstruation irregular — 1314 reaction mentions
  • incorrect product administration duration — 1311 reaction mentions
  • metrorrhagia — 1264 reaction mentions
  • weight increased — 1171 reaction mentions
  • pregnancy with implant contraceptive — 1152 reaction mentions
  • vaginal haemorrhage — 1089 reaction mentions
  • amenorrhoea — 1019 reaction mentions
  • open-targets-adr · recorded 2026-06-24 · a recorded source, not a stored snapshot

Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.

Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What is missing or unclearRead from sources, not yet reviewed

Does the exact form matter?

Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.

The form that was studied

Vaginal

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form used in the studies cited on this page.

No source is stored against this line.

What is sold

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing further is recorded about which forms are sold.

No source is stored against this line.

What is recorded as being sold

  • 22 products list this as an active ingredient in the United States drug directory. 10 of them contain it and nothing else.

    FDA National Drug Code directory · 60870-0475 · read 2026-08-29

  • They are sold as implant, insert, extended release, powder, ring and tablet, taken subcutaneous and vaginal.

    FDA National Drug Code directory · 60870-0475 · read 2026-08-29

  • The regulator's established pharmacologic class for it is progesterone congeners [cs] and progestin [epc].

    FDA National Drug Code directory · 60870-0475 · read 2026-08-29

  • 12 published labels name it as an active ingredient. 1 of them describe this substance alone, which is where its own label text on this page comes from.

    US prescribing information · 85a126f6-d3e0-9e12-73f9-6176ba36f58b · read 2026-08-29

  • Those labels are classed as human prescription drug.

    US prescribing information · 85a126f6-d3e0-9e12-73f9-6176ba36f58b · read 2026-08-29

  • Nexplanon is subcutaneous at 3 DOSAGE FORMS AND STRENGTHS Single, white/off-white, soft, radiopaque, flexible, ethylene vinyl acetate (EVA) copolymer implant, 4 cm in length and 2 mm in diameter containing 68 mg etonogestrel, 15 mg of barium sulfat…, recorded as fda label in effect 2026-05-28 in the United States.

    US prescribing information · 487f8a62-e142-457c-97cc-2e398fde7594 · read 2026-08-30

Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.

What it would be like to takeRead from sources, not yet reviewed

What you could measure

This one is decided with a clinician, so this section holds questions to ask rather than a plan to run.

Self-experiment planning is not offered for a prescription or clinician-supervised medicine. The questions below are for a clinician or pharmacist.

Questions worth asking

  • Which of the trials of Etonogestrel studied people like me?
  • What was measured, and for how long?
  • Was the result a laboratory value or a health outcome?
  • What would we watch for, and when would we stop?

Tracking can show whether something changed for you. It cannot show what caused it.

RNAWiki records evidence. It does not say whether this substance is right for you.

What is missing or unclearRead from sources, not yet reviewed

What nobody knows yet

Open questions, each with why it is open and what would close it.

Missing populations

Which groups were under-represented in the studies has not been recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing long-term data

No completed tested study window is recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

No reviewed conclusion

RNAWiki has not yet published a reviewed conclusion for this use.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing interaction studies

No interaction was found in the registers checked. Not finding one is not the same as showing there is none.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Formulation uncertainty

Several salts, forms or products of Etonogestrel are recorded. Results from one form may not transfer to another.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Mechanism not reviewed

No reviewed mechanism story exists for this substance.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

What happened in peopleRead from sources, not yet reviewed

Check any of this yourself

Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.

Where else this substance is registered

FDA substance identifier (UNII)
304GTH6RNH
RxNorm concept
389221

Checks this page had to pass

  • Passed

    Identity resolved

    no open identity hold

  • Passed

    No unresolved merge across substance families

    no quarantine open

  • Passed

    Every public sentence names a source

    The opening statement carries the origin: Written into the record, not signed off.

  • Not passed

    Trial roles classified for highlighted evidence

    No registered study is classified as testing this substance.

  • Passed

    No internal keys in reader text

    enforced by the copy-contract test over the rendered page

  • Passed

    Safety mode resolved

    Suppression classes recorded: S5.

  • Passed

    Canonical metadata present

    slug and display name present

What is missing or unclearRead from sources, not yet reviewed

How this medicine reached us

Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.

What the approval register records

  • 7 approved applications cover products containing this substance. The earliest was NDA021187, approved 20011003 to ORGANON USA ORGANON.

    Drugs@FDA application register · NDA021187 · read 2026-08-29

  • Marketing status on the register: discontinued and prescription.

    Drugs@FDA application register · NDA021187 · read 2026-08-29

  • The earliest marketing start date recorded for a listed product is 20011003.

    FDA National Drug Code directory · 60870-0475 · read 2026-08-29

What is missing or unclearRead from sources, not yet reviewed

What to learn next

Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.

This order is fixed in code and does not count clicks or time on the page.

What is not here

5 questions this page could not answer

These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.

  • The path through the body — found nothing in the sources checked.
  • What it may clash with — found nothing in the sources checked.
  • Other ways to the same goal — found nothing in the sources checked.
  • Claims that go past the evidence — found nothing in the sources checked.
  • What changed on this page — found nothing in the sources checked.

The record as stored

The full record, for auditing

Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.

Recorded evidence blocks (12)

What did Etonogestrel's largest trial (916 people) and its longest (5.3 years) measure?


916 people in Etonogestrel's largest registered study, 5.3 years in its longest registered window, measuring Percentage of Participants With Progesterone Concentrations >16 Nmol/L, by Cycle. ClinicalTrials.gov · 2026-09-01

14 phase4, 9 na or unstated, 7 phase2, 5 phase3, 2 early phase1, 2 phase1, 1 na; NCT03978598; 2024-09-19; no ageing endpoint recorded. Last human test completed 2024, NCT04626596.

Interpretation These counts include studies where Etonogestrel was a comparison treatment, a background treatment or an exposure in an observational study, and the longest window may be a planned end date. Trial roles have not yet been classified for this record.

Show the evidence
  • phase4
    14
  • na or unstated
    9
  • phase2
    7
  • phase3
    5
  • early phase1
    2
  • phase1
    2
2 more recorded rows
  • na
    1
  • Last recorded human test NCT04626596
    2024-12-30

recorded 2026-09-01 · last checked 2026-09-04

Etonogestrel was tested only in human — what did it show?


human: biomarker (38): the rungs where Etonogestrel has a recorded finding. Europe PMC and ClinicalTrials.gov · organism ladder · 2026-09-01

Percentage of Participants With Progesterone Concentrations >16 Nmol/L, by Cycle — the recorded outcome words.

Yeast C. elegans Drosophila Mouse Rat Dog Non-human primate Human biomarker
Show the evidence
  • human NCT01709318
    biomarker; Percentage of Participants With Progesterone Concentrations >16 Nmol/L, by Cycle; 38

recorded 2026-09-01 · last checked 2026-09-04

4 of Etonogestrel's trials stopped: accrual/recruitment, funding/business, other?


accrual/recruitment (2), funding/business (1) and other (1): Etonogestrel's stop wording, clustered. ClinicalTrials.gov · 2026-09-01

"Business Reasons"; 4 of 38 registered studies

Show the evidence

Trial

  • NCT00651807
    terminated; "Business Reasons"
  • NCT02669238
    terminated; "insufficient recruitment"
  • NCT03656289
    withdrawn; "IND approval from FDA was rejected and IRB approval was never granted."
  • NCT05227456
    withdrawn; "Difficulty in Recruitment"

recorded 2026-09-01 · last checked 2026-09-04

Human studies of Etonogestrel used Implanon( 68 mg etonogestrel implant) — over how long?


studies of Etonogestrel used the recorded amount. ClinicalTrials.gov · 2026-09-01

5 recorded entries; human; also "Implanon( 68 mg etonogestrel implant)", "Etonogestrel 68Mg Implant", "22.2 mg Etonogestrel (ENG)"

Show the evidence

human

  • NCT02579590
    Implanon( 68 mg etonogestrel implant)
  • NCT03589040
    Etonogestrel 68Mg Implant
  • NCT05174884
    22.2 mg Etonogestrel (ENG)
  • NCT05174884
    44.4 mg Etonogestrel (ENG)
  • NCT05227456
    Etonogestrel 68mg implant

recorded 2026-09-01 · last checked 2026-09-04

Etonogestrel's half-life is 25 hours — which schedules were studied?


25 hours, the half-life Etonogestrel's label states. openfda-label · 487f8a62-e142-457c-97cc-2e398fde7594 · 2026-08-30

Show the evidence
  • half life
    25 hours hours; Excretion The elimination half-life of etonogestrel is approximately 25 hours.
  • bioavailability
    12.3 Pharmacokinetics Absorption After subdermal insertion of the etonogestrel implant, etonogestrel is released into the circulation and is approximately 100% bioavailable.
  • metabolism
    Metabolism In vitro data shows that etonogestrel is metabolized in liver microsomes by the cytochrome P450 3A4 isoenzyme.

recorded 2026-08-30 · last checked 2026-09-04

Which of adverse events, breakthrough bleeding and/or spotting during cycle 3 and changes to mucosal function did Etonogestrel's trials measure?


adverse events, breakthrough bleeding and/or spotting during cycle 3 and changes to mucosal function lead 21 outcome terms across Etonogestrel's trials. ClinicalTrials.gov · 2026-09-01

contraceptive method discontinuation, satisfaction timing of contraceptive administration, continuation rate of contraceptive method, ovulation incidence by cycle, progesterone concentrations 16 / by cycle and breakthrough bleeding and/or spotting during cycle 3 follow.

Show the evidence
  • pregnancy
    1
  • adverse events
    1
  • continuation rate
    1
  • contraceptive method discontinuation
    1
  • satisfaction timing of contraceptive administration
    1
  • continuation rate of contraceptive method
    1
14 more recorded rows
  • ovulation incidence by cycle
    1
  • progesterone concentrations 16 / by cycle
    1
  • breakthrough bleeding and/or spotting during cycle 3
    1
  • female sexual function
    1
  • time to lactogenesis stage ii
    1
  • treatment related adverse events
    1
  • removal rate of contraceptive implants users
    1
  • satisfactory of contraceptive implant users
    1
  • ovulation implant alone
    1
  • ovulation implant and same day upa
    1
  • changes to mucosal function
    1
  • changes to mucosal health
    1
  • maximum observed serum concentration
    1
  • time to cmax
    1

recorded 2026-09-01 · last checked 2026-09-04

Which of Etonogestrel's 3 ongoing trials reports first?


3 registered trials of Etonogestrel are open; earliest completion 2026-06. ClinicalTrials.gov · 2026-09-01

Maximum observed serum concentration (Cmax); The proportion of participants who experienced endometrial changes; latest 2027-06

Show the evidence

Trial

  • NCT05174884
    "Casea S Contraceptive Implants (Casea S) Trial"; n 20; "Maximum observed serum concentration (Cmax)"; 2027-06
  • NCT05760144
    "Endometrial Biopsy in Progestin Contraceptive Users"; n 52; "The proportion of participants who experienced endometrial changes"; 2026-11
  • NCT06936436
    "the Effect of Implanon on Menstrual Patterns"; n 200; "The Effect of Implanon on Menstrual Patterns According to Timing of Insertion After Delivery"; 2026-06

recorded 2026-09-01 · last checked 2026-09-04

Which 17 trials of Etonogestrel posted no result?


Posted no result
17 of 17 completed trials
Registrations
NCT00725413, NCT01388582, NCT00931827, NCT01356927, NCT02416687 and NCT02082652, and 11 more
Completion dates
oldest 2005-11; newest 2024-04-09
Show the evidence

Trial

  • NCT00725413
    2005-11
  • NCT01388582
    2011-08
  • NCT00931827
    2011-11
  • NCT01356927
    2014-04
  • NCT02416687
    2015-01
  • NCT02082652
    2016-03
11 further recorded trials
  • NCT02480647
    2017-08
  • NCT02657148
    2018-08
  • NCT03353012
    2018-08-01
  • NCT02579590
    2019-02-01
  • NCT02594462
    2019-06
  • NCT03336346
    2019-12-11
  • NCT03398811
    2020-11-01
  • NCT05742503
    2022-03-30
  • NCT04814927
    2022-12-15
  • NCT03660046
    2023-09-07
  • NCT04423055
    2024-04-09

At the median, Etonogestrel's trials enrolled 87.5 people — anything larger?


Median enrolment
87.5
Largest enrolment
916
Registered trials counted
38

What do 12865 spontaneous reports say about Etonogestrel — and not say?


These are reports people sent to a regulator. They do not show the medicine caused the reaction. Nobody counted how many people took the medicine and reported nothing. The same event can be reported more than once, and many reports are incomplete. News coverage, lawsuits and new warnings change how often people report. A count is not a rate and not a risk.

Etonogestrel appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 12865 reaction mentions were counted: menorrhagia 1633; unintended pregnancy 1559; implant site pain 1353; menstruation irregular 1314. open-targets-adr · CHEMBL1531 · 2026-06-24

Show the evidence
  • menorrhagia
    1633
  • unintended pregnancy
    1559
  • implant site pain
    1353
  • menstruation irregular
    1314
  • incorrect product administration duration
    1311
  • metrorrhagia
    1264
4 more recorded rows
  • weight increased
    1171
  • pregnancy with implant contraceptive
    1152
  • vaginal haemorrhage
    1089
  • amenorrhoea
    1019

recorded 2026-06-24 · last checked 2026-09-04

Etonogestrel and CYP3A4 and cytochrome P450: shared by which compounds?


CYP3A4 and cytochrome P450 appear in Etonogestrel's recorded interaction sentences, 3 in all. openfda-label+europepmc · 2026-05-28

Interpretation drug_interactions

Show the evidence
  • CYP3A4 drug_interactions
    Drugs or herbal products that induce certain enzymes, such as CYP3A4, may decrease the effectiveness of progestin hormonal contraceptives or increase breakthrough bleeding.
  • cytochrome P450 drug_interactions
    ( 7.1 ) 7.1 Effects of Other Drugs on Hormonal Contraceptives Substances decreasing the plasma concentrations of hormonal contraceptives (HCs) and potentially diminishing the efficacy of HCs: Drugs or herbal products that induce certain enzymes, including cytochrome P450 3A4 (CYP3A4), may decrease the plasma concentrations of HCs and potentially diminish the effectiveness of HCs or increase…
  • CYP3A4 drug_interactions
    Substances increasing the plasma concentrations of HCs: Co-administration of certain HCs and strong or moderate CYP3A4 inhibitors such as itraconazole, voriconazole, fluconazole, grapefruit juice, or ketoconazole may increase the serum concentrations of progestins, including etonogestrel.

recorded 2026-05-28 · last checked 2026-09-04

Was Etonogestrel studied with fasting and exercise?


fasting and exercise are named in Etonogestrel's label sentences: "A 2-year prospective, randomized study of 60 implant users was performed to evaluate fasting serial serum apolipoprotein A-I, A-II, and B levels before insertion and every 3 months in users of two contraceptive implants releasing levonorgestrel (Norplant) and 3-ketodesogestrel/etonogestrel…" openfda-label+europepmc · 2026-05-28

2 recorded statements; fasting, exercise

Show the evidence
  • fasting
    A 2-year prospective, randomized study of 60 implant users was performed to evaluate fasting serial serum apolipoprotein A-I, A-II, and B levels before insertion and every 3 months in users of two contraceptive implants releasing levonorgestrel (Norplant) and 3-ketodesogestrel/etonogestrel (Implanon) in Birmingham, United Kingdom.
  • exercise
    We assessed participants' current diet, exercise, and substance (alcohol, tobacco, marijuana) use habits while simultaneously measuring serum etonogestrel concentrations.

recorded 2026-05-28 · last checked 2026-09-04

Where it is registered
Identifiers, relations and other names

The exact record

ChEMBL id
CHEMBL1531
PubChem CID
6917715
CAS number
54048-10-1
RxCUI
14584
InChIKey
GCKFUYQCUCGESZ-BPIQYHPVSA-N
Also called
Desogestrel related compound c, Implanon, eng, eng implant, etg implant, etonogestrel contraceptive implant, etonogestrel implant, etonogestrel-releasing contraceptive implant, 13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-3-one, 18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-11-METHYLENE-, DESOGESTREL IMPURITY D, DESOGESTREL IMPURITY D [EP IMPURITY]
Trade name
Etonogestrel component of nuvaring, Nexplanon, Nexplanon / Implanon
Development code
ORG 3236
Sources (9)

Sources

3 more sources
  • openfda-label 487f8a62-e142-457c-97cc-2e398fde7594 ·
  • openfda-label+europepmc K1:304GTH6RNH ·
  • national registers US, CA ·

ChEMBL ATC CC BY-SA · ClinicalTrials.gov — US Government work · Europe PMC — metadata only, under the recorded legal gate · Open Targets 26.06 — CC0 · derived from this page's own recorded fields; no external licence · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md · openFDA / DailyMed — US Government work

How these records are assembled · Which registers were checked

Index-quality checks
  • identity passed: no open identity hold
  • required summary fields resolved: 5 required field(s) not terminal: Why people use it, Best-supported result, Most important common problem, Biggest unanswered question, Human evidence
  • public claims reviewed: 0 reviewed claim(s); drafts are never rendered
  • source coverage passed: 9 source rows
  • no critical contamination: no quarantine open
  • canonical metadata passed: slug and display name present
  • no raw internal fields: enforced by the copy-contract test over the rendered page

This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.